XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
MSB Financial Corporation [Member]
Cumulative Effect Period Of Adoption Adjustment [Member]
Common Stock [Member]
Paid-in Capital [Member]
Retained Earnings [Member]
Retained Earnings [Member]
Cumulative Effect Period Of Adoption Adjustment [Member]
Unearned ESOP Shares [Member]
Accumulated Other Comprehensive Income [Member]
Balance (in value) at Jun. 30, 2020 $ 1,084,177     $ 837 $ 722,871 $ 387,911   $ (28,699) $ 1,257
Balance (in shares) at Jun. 30, 2020       83,663          
Cumulative effect of change in accounting principle for the adoption of ASU 2017-08 at Jun. 30, 2020     $ (14,239)       $ (14,239)    
Balance - July 1, 2020 as adjusted for change in accounting principle at Jun. 30, 2020 1,069,938     $ 837 722,871 373,672   (28,699) 1,257
Net Income 44,750         44,750      
Other comprehensive income (loss), net of income tax 100               100
Accretion Amortization Of ESOP Award 1,435       (25)     1,460  
Stock option exercise 373       373        
Stock option exercise (in shares)       41          
Stock repurchases (in value) (80,567)     $ (74) (80,493)        
Stock repurchases (in shares)       (7,535)          
Stock-based compensation expense 4,281       4,281        
Cancellation of shares issued for restricted stock awards (in value) (803)     $ (1) (802)        
Cancellation of shares issued for restricted stock awards (in shares)       (80)          
Shares issued in conjunction with the acquisition of MSB Financial Corp (Share).       5,854          
Shares issued in conjunction with the acquisition of MSB Financial Corp. 45,133     $ 58 45,075        
Cash dividends declared   $ (20,828)       20,828      
Balance (in value) at Mar. 31, 2021 1,063,812     $ 820 691,280 397,594   (27,239) 1,357
Balance (in shares) at Mar. 31, 2021       81,943          
Balance (in value) at Dec. 31, 2020 1,092,341     $ 849 724,389 388,376   (27,726) 6,453
Balance (in shares) at Dec. 31, 2020       84,938          
Net Income 16,423         16,423      
Other comprehensive income (loss), net of income tax (5,096)               (5,096)
Accretion Amortization Of ESOP Award 574       87     487  
Stock option exercise 373       373        
Stock option exercise (in shares)       41          
Stock repurchases (in value) (34,863)     $ (29) (34,834)        
Stock repurchases (in shares)       (3,026)          
Stock-based compensation expense 1,379       1,379        
Cancellation of shares issued for restricted stock awards (in value) (114)       (114)        
Cancellation of shares issued for restricted stock awards (in shares)       (10)          
Cash dividends declared (7,205)         7,205      
Balance (in value) at Mar. 31, 2021 1,063,812     $ 820 691,280 397,594   (27,239) 1,357
Balance (in shares) at Mar. 31, 2021       81,943          
Balance (in value) at Jun. 30, 2021 $ 1,042,944     $ 790 654,396 408,367   (26,753) 6,144
Balance (in shares) at Jun. 30, 2021 78,964,859     78,965          
Net Income $ 56,177         56,177      
Other comprehensive income (loss), net of income tax (29,093)               29,093
Accretion Amortization Of ESOP Award 1,945       486     1,459  
Stock repurchases (in value) (95,967)     $ (75) (95,892)        
Stock repurchases (in shares)       (7,468)          
Stock-based compensation expense 3,117       3,117        
Cancellation of shares issued for restricted stock awards (in value) (932)     $ (1) (931)        
Cancellation of shares issued for restricted stock awards (in shares)       (73)          
Cash dividends declared (23,022)         23,022      
Balance (in value) at Mar. 31, 2022 955,169     $ 714 561,176 441,522   (25,294) (22,949)
Balance (in shares) at Mar. 31, 2022       71,424          
Balance (in value) at Dec. 31, 2021 995,470     $ 735 587,392 431,549   (25,780) 1,574
Balance (in shares) at Dec. 31, 2021       73,453          
Net Income 17,693         17,693      
Other comprehensive income (loss), net of income tax (24,523)               24,523
Accretion Amortization Of ESOP Award 666       180     486  
Stock repurchases (in value) (26,969)     $ (21) (26,948)        
Stock repurchases (in shares)       (2,020)          
Stock-based compensation expense 676       676        
Cancellation of shares issued for restricted stock awards (in value) (124)       (124)        
Cancellation of shares issued for restricted stock awards (in shares)       (9)          
Cash dividends declared (7,720)         7,720      
Balance (in value) at Mar. 31, 2022 $ 955,169     $ 714 $ 561,176 $ 441,522   $ (25,294) $ (22,949)
Balance (in shares) at Mar. 31, 2022       71,424